Studies on Hepatoprotection by Ranitidine and Vitamin E: Rifampicin and Acetaminophen Induced   Hepatotoxicity: Preclinical Studies in Rat Models - Nilofar Naikwade - Books - LAP LAMBERT Academic Publishing - 9783845439914 - September 26, 2011
In case cover and title do not match, the title is correct

Studies on Hepatoprotection by Ranitidine and Vitamin E: Rifampicin and Acetaminophen Induced Hepatotoxicity: Preclinical Studies in Rat Models


Get an email once the item is available
Do you have a profile? Log in
Get notified about new Nilofar Naikwade releases
Add to your iMusic wish list

Not rated yet

The liver is an important target of the toxicity of drugs, xenobiotics, and oxidative stress. Liver diseases are serious public health issues in our nation, as it currently affects more than 60 million worldwide. Liver ailments remain one of the serious health problems. Wide prevalence of liver diseases and lack of hepatoprotective agents necessitated to develop satisfactory remedies for its protection. More than 600 drugs have been implicated in cases of hepatic injury; thus, recognizing drug induced liver diseases is an important and challenging task for clinics. This book, therefore, provides the crucial role of cytochome P-450 in mechanisms of liver injury and methods of monitoring hepatic functions in animals. The book mainly focuses on hepatoprotective potential of cytochrome P-450 enzyme inhibitors against drug induced hepatotoxicity in preclinical rat models by assessing liver enzymes, antioxidant parameters and cytochrome P-450. The data should be especially useful to students, researchers working in the fields of hepatology, liver problems and drug screening, or anyone else who may be considering utilizing the methods drug development process and for marketing efforts.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released September 26, 2011
ISBN13 9783845439914
Publishers LAP LAMBERT Academic Publishing
Pages 64
Dimensions 150 × 4 × 226 mm   ·   113 g
Language German